These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32205770)

  • 1. Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents: A Position Paper of the Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition.
    Indolfi G; Fischler B; Gonzalez-Peralta RP; Ciocca M; Porta G; Neelam M; El-Guindi M; Kelly D; Ni YH; Sibal A; Leung DH; Chang MH;
    J Pediatr Gastroenterol Nutr; 2020 May; 70(5):711-717. PubMed ID: 32205770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
    Indolfi G; Hierro L; Dezsofi A; Jahnel J; Debray D; Hadzic N; Czubkowski P; Gupte G; Mozer-Glassberg Y; van der Woerd W; Smets F; Verkade HJ; Fischler B
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):505-515. PubMed ID: 29287014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines.
    Malik F; Bailey H; Chan P; Collins IJ; Mozalevskis A; Thorne C; Easterbrook P
    JHEP Rep; 2021 Apr; 3(2):100227. PubMed ID: 33665586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis B and C in children.
    El-Shabrawi M; Hassanin F
    Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Singal AG; Lim JK; Kanwal F
    Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology.
    Couri T; Aronsohn A
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2015-2019. PubMed ID: 32445954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct-acting antivirals for children and adolescents with chronic hepatitis C.
    Indolfi G; Serranti D; Resti M
    Lancet Child Adolesc Health; 2018 Apr; 2(4):298-304. PubMed ID: 30169301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [JSH guidelines for the management of hepatitis C virus infection (version 3)].
    Tanaka A
    Nihon Rinsho; 2015 Feb; 73(2):221-7. PubMed ID: 25764674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents.
    Mack CL; Gonzalez-Peralta RP; Gupta N; Leung D; Narkewicz MR; Roberts EA; Rosenthal P; Schwarz KB;
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):838-55. PubMed ID: 22487950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic HCV genotype 1 coinfection.
    Boesecke C; Rockstroh JK
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation.
    Charlton MR; Gane EJ; Shukla A; Dashtseren B; Duger D; Muljono DH; Payawal DA; Jargalsaikhan G; Purnomo HD; Cua IH; Hasan I; Sollano J; Win KM; Lesmana LA; Salih M; Thi Thu Thuy P; Shankar R; Saraswat VA
    Transplantation; 2019 Apr; 103(4):733-746. PubMed ID: 30335692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper.
    Leung DH; Squires JE; Jhaveri R; Kerkar N; Lin CH; Mohan P; Murray KF; Gonzalez-Peralta RP; Roberts EA; Sundaram SS
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):407-417. PubMed ID: 32826718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives.
    Harrington PR; Komatsu TE; Deming DJ; Donaldson EF; O'Rear JJ; Naeger LK
    Hepatology; 2018 Jun; 67(6):2430-2448. PubMed ID: 29194682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cascade of care for children and adolescents with chronic hepatitis C.
    Rogers ME; Balistreri WF
    World J Gastroenterol; 2021 Mar; 27(12):1117-1131. PubMed ID: 33828389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Hepatitis C Virus Infection in Dialysis Patients.
    Kikuchi K
    Contrib Nephrol; 2018; 196():119-122. PubMed ID: 30041215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
    Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: The role of prior treatment with interferon plus ribavirin.
    Alsius M; Ferri MJ; Buxó M; López C; Serra I; Queralt X; Acero D
    Gastroenterol Hepatol; 2019 Feb; 42(2):82-89. PubMed ID: 30446175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
    Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
    J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C.
    Kawagishi N; Suda G; Onozawa M; Kimura M; Maehara O; Ohara M; Izumi T; Umemura M; Ito J; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N
    J Viral Hepat; 2017 Dec; 24(12):1098-1106. PubMed ID: 28632923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.